大韓民国で最高の卵巣嚢胞医師 - トップ9名の医師

ソウルミズ病院の最高医療責任者であるパク医師は、卵巣腫瘍および婦人科疾患に対する腹腔鏡手術を専門としています。

• 韓国の複数の名門医科大学における客員教授
• 韓国産科婦人科学会会員
• ハイリスク妊娠管理および子宮内膜症の専門家
• 婦人科がん検診を含む女性医療サービスを統括

Dr. Ki Yeol Yang, MD, PhD, is the Founder and Representative Director of Trinity Women’s Clinic. She is a menopause specialist and a pioneer in uterus-preserving, minimally invasive gynecology. She is a Korean board-certified OB/GYN and a certified menopause specialist (Korean Menopause Society). Her practice, informed by tens of thousands of clinical cases, provides individualized HRT and precision care.

She is experienced in HIFU and RFA for fibroids and adenomyosis, laser vaginal rejuvenation, and functional pelvic floor reconstruction. She is a Clinical Professor at Kyung Hee University Medical Centre. She serves as Director of Academic Affairs for the Korean Medical Practitioners’ Association and as Business Director for the Korean Therapeutic Ultrasound Medical Association. She is also the author of a menopause patient guide.

Founder of Trinity Women’s Clinic. Recognized as a Master Surgeon in minimally invasive gynecology and female aesthetic surgery. Pioneers uterus‑preserving, scar‑less care using RFA, HIFU, and ovarian sclerotherapy.

Professor of Non‑surgical Female Plastic Surgery at IFAAS. Leads international RFA Master Classes in Taiwan and Mongolia. Director of General Affairs at the Korean Society of HIFU. Holds director roles with KMPA, KCOG, and the Korean Society of Therapeutic Ultrasound.

MD/PhD, Korea University. Fellowship in Gynecologic Oncology at Korea University Medical Center. HIFU training at Fudan University. Preceptorship at Uppsala University. Former Medical Affairs executive at MSD, Takeda, and Novo Nordisk. Key Doctor and consultant to Bayer, Novo Nordisk, PharmaResearch, and RF Medical. Member of AACR and IGCS. Medical advisor on Channel A and TV Chosun.

HEESEOK KANGDepartment of Obstetrics

• Education/Academic career
• Graduated from Yonsei University College of Medicine
• Internship, Samsung Medical Center
• Residency and M.D., Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology, Gyeonggi Provincial Medical Center Pocheon Hospital
• Clinical Instructor, Obstetrics and Gynecology, Samsung Medical Center
• Head of Department, Obstetrics and Gynecology I, Good Morning Hospital
• Head of Department, Obstetrics and Gynecology, Daerim St. Mary’s Hospital
• Director of Obstetrics and Gynecology & Academic Affairs of Medical Department , Hismedi Hospital
• Head of Department, Heryoujae Women’s Hospital
• Current)Adjunct Professor, Obstetrics and Gynecology, Samsung Medical Center
• Current)Expert for NAVER KnowledgeiN
• Professional memberships
• Award for Exemplary Safety Management, Samsung Medical Center, 2002
• Award for Excellence in QI Poster, Samsung Medical Center, 2007
• Outstanding Thesis Award, Korean Society of Gynecologic Oncology and Colposcopy, 2008
•  
• [Thesis]
•  
• 1. Single port access laparoscopic adnexal surgery. Kim TJ, Lee YY, Kim MJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. J Minim Invasive Gynecol. 2009 SepOct;16(5):6125.
• 2. The prognostic significance of the SUVmax (maximum standardized uptake value for F18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results. Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG. Gynecol Oncol. 2009 Oct;115(1):658. Epub 2009 Jul 15.
• 3. Singleport access laparoscopicassisted vaginal hysterectomy: a novel method with a wound retractor and a glove. Lee YY, Kim TJ, Kim CJ, Kang H, Choi CH, Lee JW, Kim BG, Lee JH, Bae DS. J Minim Invasive Gynecol. 2009 JulAug;16(4):4503. Epub 2009 May 31.
• 4. Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a singleinstitutional phase II study. Kang H, Kim TJ, Lee YY, Choi CH, Lee JW, Bae DS, Kim BG. Gynecol Oncol. 2009 Aug;114(2):2104. Epub 2009 May 14.
• 5. MR Imaging in Endometrial Carcinoma as a Diagnostic Tool for the Prediction of Myometrial Invasion and Lymph Node Metastasis. Ryoo UN, Choi CH, Yoon JY, Noh SK, Kang H, Kim WY, Kim BH, Kim TJ, Lee JW, Lee JH, Kim BG, Bae DS. Cancer Res Treat. 2007 Dec;39(4):16570. Epub 2007 Dec 31.
• 6. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Choi CH, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199204.
• 7. Lowgrade endometrial stromal sarcoma: a single center's experience with 22 cases. Kim WY, Lee JW, Choi CH, Kang H, Kim TJ, Kim BG, Lee JH, Bae DS. Int J Gynecol Cancer. 2008 SepOct;18(5):10849.
• 8. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS. Gynecol Oncol. 2008 Oct;111(1):10610.
• 9. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS. BMC Cancer. 2008 Oct 11;8:295.
• 10. Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer Kang H, Kim TJ, Choi CH, Lee JW, Lee JH, Bae DS, Kim BG. JKMS. 2009 Oct. (in press)
• 11. Ritodrine hydrochloride 단독 투여와 magnesium sulfate와의 병합 투여의 조기진통 억제효과 및 안정성에 대한 비교 김영아, 강희석, 양순하, 김종화 대한산부인과학회 2002;45:1991.
• 12. Experience of Surgical Treatment for Adnexal Lesions in Adolescent Patients 이은주, 강희석, 윤병구, 배덕수, 최두석 대한산부내시경 2002;14:79
• 13. 태아간 수혈증후군이 의심되는 단일 융모막성 쌍태임신에서 발견된 일측 쌍생아의 선천성 뇌실주위 백질 연화증 1예 강희석, 양순하, 오성희, 강병희, 노정래, 김종화 대한산부인과학회 2002:45:841
• 14. 자궁근종 치료에서 modified LAM 기법의 타당성 조사 연구 이은주, 김태중, 지현영, 김하정, 김철중, 이유영, 강희석, 최철훈, 이정원, 김병기, 배덕수 대한산부내시경 2008;20:35
• 15. 위암, 유방암, 난소암의 원발성 중복암이 있었던 환자의 증례보고 최현진, 최철훈, 김태중, 강희석, 이은주, 이정원, 김병기, 이제호, 배덕수 대한산부인과학회 2008;51:1519
• 16. Factors associated with complicationsand conversion to laparotomy in women undergoing laparoscopically assistedvaginal hysterectomy. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Acta Obstet Gynecol Scand. 2012 May;91(5):6204.
• 17. A review of the technique and complicationsfrom 2,012 cases of laparoscopically assisted vaginal hysterectomy at a singleinstitution. Song T, Kim TJ, Kang H, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS. Aust N Z J Obstet Gynaecol. 2011 Jun;51(3):23943.
• 18. The use of misoprostol beforehysteroscopic surgery in nonpregnant premenopausal women: a randomizedcomparison of sublingual, oral and vaginal administrations. Lee YY, Kim TJ, Kang H, Choi CH, Lee JW, Kim BG, Bae DS. Hum Reprod. 2010 Aug;25(8):19428.
• 19. Prognostic significance of pSTAT3 inpatients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy. Choi CH, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS. J Obstet Gynaecol Res. 2010 Apr;36(2):30410.
• 20. Outcome and reproductive function after cumulative highdose combination chemotherapy with bleomycin, etoposideand cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Kang H, Kim TJ, Kim WY, Choi CH, Lee JW, Kim BG, Bae DS.

ナ・ヨンベ医師は、ソウルミズ病院において、卵巣嚢腫に対するロボット手術および腹腔鏡手術を含む低侵襲婦人科手術を専門としています。

• 高麗大学医科大学卒業
• 高麗大学医療院にて研修修了
• 韓国婦人科内視鏡学会会員
• 月経異常の診断および治療に精通

Dr. Kim Chang-il is a specialist in Obstetrics and Gynecology. He is the Director of the Robotic Surgery Center and the Uterine Fibroid Center at Naeun Hospital. He specializes in robotic laparoscopy and uterine and ovarian preservation. He treats severe adenomyosis, large uterine fibroids, endometriosis, ovarian cysts, chronic pelvic pain, urinary incontinence, and menopause.

Former roles include Head of OB/GYN at Pohang St. Mary’s Hospital; Deputy Director of Gynecology at Dongtan Jeil Hospital; Head of Gynecology at Geomdan Top Hospital; and Head of OB/GYN at His Medi Hospital.

He is a full member of the Korean Society of Obstetrics and Gynecology, the Korean Society of Gynecologic Endoscopy & Minimally Invasive Surgery, the Korean Society of Endometriosis, the Korean Society of Gynecologic Oncology, the Korean Pelvic Nerve Research Society, and the Korean Society of Menopause. He is a lifetime member of the Korean Society of Single-Port Surgery.

Department of Gynecology

YEJI LEE

• Education/Academic career
• Master of Science, Seoul National University Department of Biomedical Sciences
• Internship, Seoul National University Hospital
• Residency, Obstetrics and Gynecology, Seoul National University Hospital
• Specialist in Obstetrics and Gynecology, Seoul National University Hospital
• Chief Director, Injung Hospital
• Treating international patients in Raphael Clinic
• Professional memberships
• Member, Korean Society of Obstetrics and Gynecology
• Member, Korean Society of Ultrasound in Obstetrics and Gynecology
• Member, Korean Society of Maternal Fetal Medicine
• Member, Doctors without Borders
•  
• [Thesis]
•  
• 1. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia BH Kim, JM Lee, YJ Lee, KB Lee, KS Suh, JK Han, BI Choi Journal of Magnetic Resonance Imaging 34 (5), 11101116 126 2011
• 2 .MR elastography for noninvasive assessment of hepatic fibrosis: reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement YJ Lee, JM Lee, JE Lee, KB Lee, ES Lee, JH Yoon, MH Yu, JH Baek, ... Journal of magnetic resonance imaging 39 (2), 326331 110 2014
• 3. An artificial intelligence electrocardiogram analysis for detecting cardiomyopathy in the peripartum period Y Lee, B Choi, MS Lee, U Jin, S Yoon, YY Jo, J Kwon International Journal of Cardiology 352, 7277 14 2022
• 4. Analysis of falsely elevated risk of ovarian malignancy algorithm in women with ovarian endometrioma JJ Shin, YJ Lee, R Kim, DY Lee, KH Won, BC Jee Obstetrics & Gynecology Science 59 (4), 295 5 2016

Dr. Do‑young Jeong is an obstetrician‑gynecologist focused on minimally invasive, single‑port, and robotic surgery. Dr. Jeong completed an internship at Seoul National University Hospital. Dr. Jeong completed residency and graduate training at Korea University. Dr. Jeong then completed a fellowship in gynecologic oncology at the National Cancer Center, focusing on uterine and ovarian disease. Dr. Jeong served as director and chief medical officer at MizMedi Hospital and Incheon Sejong Hospital. Dr. Jeong later served as vice president at Dongtan Jeil Hospital. Dr. Jeong is a Clinical Professor at Kyung Hee University Hospital at Gangdong and an Adjunct Professor at Korea University. Dr. Jeong also serves on expert committees for KSGO, MOHW, MFDS, and KHIDI.

Professional memberships include the Korean societies for obstetrics and gynecology, gynecologic endoscopy, gynecologic robotic surgery, and reproductive medicine, as well as ISUOG. Dr. Jeong holds patents for single‑port surgical devices, including a camera, access ring, and irrigation system. Honors include the Korea University Outstanding Resident Award and the KSGE Best Poster Award. Dr. Jeong was first author of SCI‑indexed papers in 2013 and 2014. From 2023 to 2025, Dr. Jeong led studies on da Vinci SP myomectomy and hysterectomy, and on HIFU.